Dexamethasone increases angiopoietin-1 and quiescent hematopoietic stem cells: A novel mechanism of dexamethasone-induced hematoprotection

FEBS Letters

Volumn 582, Issue 23-24, 2008, Pages 3509-3514

  Kim, Hyongbum ^a,b   Choi, Ji Young ^c   Lee, Jung Min ^a,d   Park, Yoon Shin ^a   Suh, Hwal ^b   Song, Hae Ryong ^e   Jo, Sangmee Ahn ^a   Jo, Inho ^c  

^a Korea National Institute of Health   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

Angiopoietin 1; Bone marrow; Dexamethasone; Hematopoietic stem cells; Hematoprotection

Indexed keywords

ANGIOPOIETIN 1; CD45 ANTIGEN; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL PROTECTION; CELL SORTER; CONTROLLED STUDY; DRUG INHIBITION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; UPREGULATION; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANIMALS; BASE SEQUENCE; BONE MARROW; CYTOPROTECTION; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; MICE; MICE, INBRED C57BL; MYELOID PROGENITOR CELLS; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; RNA STABILITY; RNA, MESSENGER;

EID: 53049107841     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.09.021     Document Type: Article

References (29)

1. LeMaistre C.F., and Knight III W.A. High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors. Invest. New Drugs 1 (1983) 321-329
2. Kriegler A.B., Bernardo D., and Verschoor S.M. Protection of murine bone marrow by dexamethasone during cytotoxic chemotherapy. Blood 83 (1994) 65-71
3. Elmas S.A., Cetin M., Tuncer M., and Hicsonmez G. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia. Am. J. Hematol. 80 (2005) 1-5
4. Dumont D.J., Yamaguchi T.P., Conlon R.A., Rossant J., and Breitman M.L. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7 (1992) 1471-1480
5. Iwama A., Hamaguchi I., Hashiyama M., Murayama Y., Yasunaga K., and Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem. Biophys. Res. Commun. 195 (1993) 301-309
6. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
7. Maisonpierre P.C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
8. Sato A., Iwama A., Takakura N., Nishio H., Yancopoulos G.D., and Suda T. Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int. Immunol. 10 (1998) 1217-1227
9. Arai F., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
10. Hare L.E., Yeh K.C., Ditzler C.A., McMahon F.G., and Duggan D.E. Bioavailability of dexamethasone. II. Dexamethasone phosphate. Clin. Pharmacol. Ther. 18 (1975) 330-337
11. van Pelt K., de Haan G., Vellenga E., and Daenen S.M. Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cells. Exp. Hematol. 33 (2005) 226-231
12. Arai F., Ohneda O., Miyamoto T., Zhang X.Q., and Suda T. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J. Exp. Med. 195 (2002) 1549-1563
13. Kim H., et al. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate. Biochem. Biophys. Res. Commun. 332 (2005) 1053-1060
14. Min J., Jin Y.M., Moon J.S., Sung M.S., Jo S.A., and Jo I. Hypoxia-induced endothelial NO synthase gene transcriptional activation is mediated through the tax-responsive element in endothelial cells. Hypertension 47 (2006) 1189-1196
15. Chaudhary L.R., and Avioli L.V. Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J. Biol. Chem. 271 (1996) 16591-16596
16. Sacchetti B., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131 (2007) 324-336
17. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182 (2000) 311-322
18. Yamazaki S., Iwama A., Takayanagi S., Morita Y., Eto K., Ema H., and Nakauchi H. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J. 25 (2006) 3515-3523
19. Osawa M., Hanada K., Hamada H., and Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273 (1996) 242-245
20. Arai F., and Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann. N. Y. Acad. Sci. 1106 (2007) 41-53
21. Miura Y., et al. Mesenchymal stem cell-organized bone marrow elements: an alternative hematopoietic progenitor resource. Stem Cells 24 (2006) 2428-2436
22. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., and Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell Physiol. 176 (1998) 57-66
23. Stacker S.A., Runting A.S., Caesar C., Vitali A., Lackmann M., Chang J., Ward L., and Wilks A.F. The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2. Growth Factors 18 (2000) 177-191
24. Kim H., Lee J.M., Park J.S., Jo S.A., Kim Y.O., Kim C.W., and Jo I. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem. Biophys. Res. Commun. 372 (2008) 243-248
25. Hangai M., Murata T., Miyawaki N., Spee C., Lim J.I., He S., Hinton D.R., and Ryan S.J. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1617-1625
26. Schaaf M.J., and Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 83 (2002) 37-48
27. Newton R. Molecular mechanisms of glucocorticoid action: what is important?. Thorax 55 (2000) 603-613
28. Duma D., Jewell C.M., and Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102 (2006) 11-21
29. Adcock I.M., Ito K., and Barnes P.J. Glucocorticoids: effects on gene transcription. Proc. Am. Thorac. Soc. 1 (2004) 247-254